These agreements were created for a number of reasons, among which was the disproportionate monetary advantage developed countries were realizing in the pharmaceutical market.
Disse aftaler blev indgået af en række grunde, herunder den økonomiske forfordelingen af ulandene på det farmaceutiske marked.